Carson Wealth (CWM LLC)’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$224K Buy
16,199
+1,137
+8% +$15.8K ﹤0.01% 2638
2025
Q4
$211K Buy
15,062
+3,177
+27% +$44.6K ﹤0.01% 2529
2025
Q3
$166K Buy
11,885
+156
+1% +$2.25K ﹤0.01% 2586
2025
Q2
$176K Sell
11,729
-522
-4% -$7.45K ﹤0.01% 2284
2025
Q1
$162K Sell
12,251
-2,076
-14% -$28.6K ﹤0.01% 2065
2024
Q4
$226K Buy
14,327
+92
+0.6% +$1.38K ﹤0.01% 1749
2024
Q3
$226K Sell
14,235
-40
-0.3% -$644 ﹤0.01% 1695
2024
Q2
$218K Buy
14,275
+1,355
+10% +$19.4K ﹤0.01% 1544
2024
Q1
$190K Buy
12,920
+2,050
+19% +$29.9K ﹤0.01% 1542
2023
Q4
$151K Buy
10,870
+2,990
+38% +$40K ﹤0.01% 1548
2023
Q3
$105K Sell
7,880
-1,100
-12% -$14.9K ﹤0.01% 1595
2023
Q2
$113K Buy
8,980
+805
+10% +$9.4K ﹤0.01% 1513
2023
Q1
$93K Buy
8,175
+2,475
+43% +$26.7K ﹤0.01% 1529
2022
Q4
$59K Buy
5,700
+1,105
+24% +$11.9K ﹤0.01% 1640
2022
Q3
$48K Sell
4,595
-205
-4% -$2.18K ﹤0.01% 1677
2022
Q2
$53K Buy
4,800
+1,120
+30% +$12.2K ﹤0.01% 1608
2022
Q1
$41K Buy
3,680
+685
+23% +$7.77K ﹤0.01% 1692
2021
Q4
$39K Buy
+2,995
New +$37.8K ﹤0.01% 1679
2021
Q2
$36K Hold
2,465
﹤0.01% 1545
2021
Q1
$36K Hold
2,465
﹤0.01% 1545
2020
Q4
$36K Hold
2,465
﹤0.01% 1545
2020
Q3
$36K Hold
2,465
﹤0.01% 1545
2020
Q2
$36K Hold
2,465
﹤0.01% 1545
2020
Q1
$36K Hold
2,465
﹤0.01% 1545
2019
Q4
$36K Hold
2,465
﹤0.01% 1545
2019
Q3
$36K Hold
2,465
﹤0.01% 1545
2019
Q2
$36K Hold
2,465
﹤0.01% 1545
2019
Q1
$36K Buy
2,465
+2,210
+867% +$16.8K ﹤0.01% 1545
2018
Q4
$2K Hold
255
﹤0.01% 1787
2018
Q3
$2K Hold
255
﹤0.01% 1555
2018
Q2
$2K Buy
+255
New +$1.61K ﹤0.01% 1415
2017
Q1
Sell
-115
Closed -$1K 1291
2016
Q4
$1K Buy
+115
New +$1.07K ﹤0.01% 1070
2016
Q3
Sell
-1,110
Closed -$11K 1052
2016
Q2
$11K Hold
1,110
﹤0.01% 548
2016
Q1
$10K Hold
1,110
﹤0.01% 530
2015
Q4
$10K Buy
+1,110
New +$12.2K ﹤0.01% 471

Other funds holding RDY

Carson Wealth (CWM LLC)'s RDY Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Dr. Reddy's Laboratories (RDY) stake by 7.5% in Q1 2026, buying an estimated $15.8K and bringing the position to 16,199 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #2638.

Carson Wealth (CWM LLC) first reported a position in RDY in Q4 2015 and has held it in 35 quarters since. The position peaked at $226K in Q4 2024. 249 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Carson Wealth (CWM LLC) held 16,199 shares of Dr. Reddy's Laboratories worth $224K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 1,137 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $15.8K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2638 holding.
  • Carson Wealth (CWM LLC) first reported a position in Dr. Reddy's Laboratories in Q4 2015 and has held it in 35 quarters since.
  • Carson Wealth (CWM LLC)'s Dr. Reddy's Laboratories position peaked at $226K in Q4 2024.
  • 249 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.